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National Defense Medical Center, Taipei, TaiwanReceived 25 December 2014; received in revised form 3 March 2015; accepted 25 March 2015A 5-year-old boy came to our outpatient clinic because of
polyuria and polydipsia. His urine output was approximately
3.5 L/d. His laboratory data showed normal serum elec-
trolytes and osmolality. The boy later suffered from vom-
iting and general weakness. He visited our emergency
department and was hospitalized because of severe hypo-
kalemia (1.9 mmol/L). His blood pressure was 105/
73 mmHg. The blood gas tests initially showed metabolic
alkalosis (pH 7.45, pCO2 40.0 mmHg, HCO3
e 27.5 mmol/L),
where the urine chloride level was 14 mmol/L. The frac-
tional excretion of potassium and sodium was 78.7% and
2.2%, respectively. Hypercalciuria was also noted [urine Ca
(mg/dL)/urine Cr (mg/dL) Z 1.69]. Furthermore, renal
sonography revealed bilateral medullary nephrocalcinosis,
hydronephrosis, and hydroureters (Fig. 1). Because Bartter
syndrome (BS) was suspected, molecular gene analysis was
carried out. Two intronic mutations in the NaþeKþe2Cle
cotransporter genedone in the consensus splicing site and
the other as deep intronic mutationdconfirmed the diag-
nosis of type I BS. In addition, marked polyuria was noted
with urine output up to 11 L/d. Urine osmolality was only 64
mOsm/kg H2O. Water deprivation test and pitressin testConflicts of interest: The authors have no conflicts of interest
relevant to this article.
* Corresponding author. National Taiwan University Hospital,
Number 8, Chung Shan South Road, Taipei 10041, Taiwan.
E-mail address: ijtsai@ntu.edu.tw (I.-J. Tsai).
http://dx.doi.org/10.1016/j.jfma.2015.03.017
0929-6646/Copyright ª 2015, Formosan Medical Association. Published
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/confirmed the presence of nephrogenic diabetes insipidus
(NDI). The molecular study found no mutations in the AVPR2
or the AQP2 gene. Therefore, the final diagnosis was type I
BS with secondary NDI. The patient received oral potassium
chloride and spironolactone after discharge; follow-up
visits showed an acceptable serum potassium level
(3.2e3.7 mEq/L) and urine output of approximately
2e3 L/d.
Polyuria has generally been defined as urine output
exceeding 2 L/m2/d in children and 6 mL/kg/h in neonates.
It could either be hyposthenuria during diabetes insipidus
or isosthenuria in conditions such as BS and solute diuresis.
This separates type I BS patients from polyuric patients
with NDI, who typically display urine osmolality below 100
mOsm/kg H2O.
Primary or hereditary NDI refers to mutation(s) in the
AVPR2 gene or the AQP2 gene. Secondary NDI is attributable
to hypercalciuria, hypokalemia, lithium, or the use of
certain antibiotics.1 Hypercalciuria is thought to affect
AQP2 expression, probably via the calcium-sensing recep-
tor, which is present in the apical membrane of medullary
collecting duct cells and inhibits cyclic adenosine mono-
phosphate formation.2 In animal models, hypokalemia is
associated with decreased expression of AQP2.3 Thus, a
characteristic combination of hypokalemia and hyper-
calciuria in type I BS could be the cause of secondary NDI.
Type I BS, or antenatal BS, is a rare autosomal
recessive disorder characterized by salt wasting fromby Elsevier Taiwan LLC. This is an open access article under the
4.0/).
Figure 1 Bilateral medullary nephrocalcinosis, hydronephrosis, and hydroureters on renal ultrasound (white arrows indicate
hydroureters).
Antenatal BS resembling NDI 383the thick ascending limb of Henle’s loop owing to mu-
tation in the SCL12A1 gene, which encodes the
NaþeKþe2Cle cotransporter.4 Patients typically present
with maternal polyhydramnios during the fetal period;
life-threatening volume depletion, hypokalemia, meta-
bolic alkalosis, along with hypercalciuria and medullary
nephrocalcinosis will be noted after birth. Without
appropriate treatment, patients with antenatal BS will
not survive the early neonatal period. However, late-
onset presentation with milder phenotype has been re-
ported with compound heterozygous mutations in the
SLC12A1 gene.5
In summary, we delineated a case of antenatal BS pre-
senting coincidentally with NDI beyond the age of infancy.
Secondary NDI could be caused by hypercalciuria and hy-
pokalemia. The late-onset phenotype observed in our pa-
tient may be explained by a novel compound mutation in
the SLC12A1 gene.References
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